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Abstract 
Defective axonal transport is an early neuropathological feature of amyotrophic lateral sclerosis 
(ALS). We have previously shown that ALS-associated mutations in Cu/Zn superoxide dismutase 
1 (SOD1) impair axonal transport of mitochondria in motor neurons isolated from SOD1 G93A 
transgenic mice and in ALS mutant SOD1 transfected cortical neurons, but the underlying 
mechanisms remained unresolved. 
The outer mitochondrial membrane protein mitochondrial Rho GTPase 1 (Miro1) is a master 
regulator of mitochondrial axonal transport in response to cytosolic calcium (Ca2+) levels ([Ca2+]c) 
and mitochondrial damage. Ca2+ binding to Miro1 halts mitochondrial transport by modifying its 
interaction with kinesin-1 whereas mitochondrial damage induces Phosphatase and Tensin 
homolog (PTEN)-induced putative kinase 1 (PINK1) and Parkin-dependent degradation of Miro1 
and consequently stops transport. 
To identify the mechanism underlying impaired axonal transport of mitochondria in SOD1-related 
ALS we investigated [Ca2+]c and Miro1 levels in ALS mutant SOD1 expressing neurons. We found 
that expression of ALS mutant SOD1 reduced the level of endogenous Miro1 but did not affect 
[Ca2+]c. ALS mutant SOD1 induced reductions in Miro1 levels were Parkin dependent. Moreover, 
both overexpression of Miro1 and ablation of PINK1 rescued the mitochondrial axonal transport 
deficit in ALS mutant SOD1-expressing cortical and motor neurons. 
Together these results provide evidence that ALS mutant SOD1 inhibits axonal transport of 
mitochondria by inducing PINK1/Parkin-dependent Miro1 degradation. 
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Introduction 
Amyotrophic lateral sclerosis (ALS) is an adult onset neurodegenerative disorder, which is 
characterised by the selective death of motor neurons in the spinal cord, motor cortex and brain 
stem (1). Approximately 10% of all ALS cases are inherited and mutations in a number of genes 
have been associated with ALS, including superoxide dismutase 1 (SOD1), TAR DNA binding 
protein (TARDBP; TDP-43), Fused in sarcoma (FUS), and C9orf72 (2). Approximately 185 
different mutations in the enzyme Cu/Zn superoxide dismutase-1 (SOD1) have been associated 
with ALS (3) and it is generally accepted that these mutations cause ALS by toxic-gain-of-function 
mechanisms. Several toxic mechanisms have been proposed including, among others, 
excitotoxicity, neuroinflammation, loss of protein homeostasis, mitochondrial dysfunction, and 
defective axonal transport (4Ð7) 
Neuronal function, integrity and survival are largely dependent on the correct distribution of 
proteins and organelles to their designated destinations. The architecture of neurons renders them 
particularly vulnerable to disruptions of transport processes and numerous lines of evidence 
suggest that defective axonal transport contributes to human neurodegenerative diseases including 
ALS (8). We and others have shown that impaired axonal transport is a very early event in both in 
vitro and in vivo models of ALS (5). In case of SOD1-related ALS we have shown that ALS mutant 
SOD1 selectively reduced anterograde transport of mitochondria in primary cortical and motor 
neuron cultures (9). Subsequent time-lapse recordings in single axons in the intact sciatic nerve of 
presymptomatic SOD1 G93A transgenic mice and rats revealed deficits in both anterograde and 
retrograde axonal transport of mitochondria in vivo (10Ð12). 
Molecular motors transport mitochondria bi-directionally along axonal microtubules in response 
to physiological stimuli and energy requirements. Anterograde axonal transport of mitochondria 
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is mediated by kinesin-1 whereas retrograde transport is mediated by cytoplasmic dynein. Both 
kinesin-1 and cytoplasmic dynein connect to mitochondria via atypical mitochondrial Rho GTPase 
1 (Miro1) and the adaptor proteins Trafficking Kinesin protein (TRAK) 1 and 2 (13Ð22). Miro1 is 
a key regulator of axonal mitochondrial transport in response to calcium (Ca2+) and mitochondrial 
damage (16, 23Ð26). Binding of Ca2+ to the Miro1 EF-hand motifs modulates its interaction with 
kinesin-1 such that the kinesin-1 motor domain directly binds to Miro1 and is thereby blocked 
from binding to microtubules, or, alternatively, kinesin-1 is released from mitochondria (24, 25). 
Mitochondrial damage leads to phosphorylation of Miro1 by Phosphatase and Tensin homolog 
(PTEN)-induced putative kinase 1 (PINK1) which targets Miro1 for Parkin-dependent 
proteasomal degradation and consequently causes an irreversible detachment of molecular motors 
from the mitochondrial surface (23, 26, 27).  
Here we investigated the mechanism underlying impaired axonal transport of mitochondria in 
SOD1-related ALS. We report that ALS mutant SOD1 reduces anterograde mitochondrial 
transport by inducing PINK1/Parkin-dependent degradation of Miro1. 
 
Results 
ALS mutant SOD1 impairs axonal transport of mitochondria after lentiviral delivery in primary 
rat motor neurons. 
We have shown previously that ALS mutant SOD1 disrupts axonal transport of mitochondria in 
transfected primary embryonic rat cortical neurons and in embryonic SOD1 G93A transgenic 
mouse motor neurons (9). To test if this defect could be recapitulated by expressing ALS mutant 
SOD1 in primary cultures of embryonic rat motor neurons we delivered EGFP, EGFP-SOD1 wild 
type (WT), A4V, G37R or G93A to DIV3 rat motor neurons by lentiviral transduction and 
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analysed axonal transport of MitoTracker Red CMXRos-labelled mitochondria from time-lapse 
recordings and corresponding kymographs as described by us before (Fig. 1A, a) (9, 28, 29). As a 
positive control, we quantified axonal transport in rat cortical neurons co-transfected with EGFP, 
EGFP-SOD1 WT or G93A and DsRed2-mito (Fig. 1B, a) (9). 
In EGFP and EGFP-SOD1 WT transduced motor neurons approximately 50% of mitochondria 
were motile and anterograde and retrograde transport was balanced (Fig. 1A, b and c). Lentiviral 
delivery of EGFP-SOD1 A4V, G37R or G93A significantly reduced anterograde transport of 
mitochondria while retrograde transport remained unchanged (Fig. 1A, b); as a result, the balance 
of transport shifted toward net retrograde transport (Fig. 1A, c).  
In EGFP and EGFP-SOD1 WT-expressing cortical neurons approximately 45% of mitochondria 
were motile, with near equal amounts of mitochondria moving in anterograde and retrograde 
directions (Fig. 1B, b). EGFP-SOD1 G93A caused a significant reduction in the number of 
anterograde mitochondria but did not affect the number of retrograde mitochondria (Fig. 1B, b). 
As a result, there was a significant shift toward net retrograde mitochondrial transport (Fig. 1B, c). 
Transfection of ALS mutant SOD1 did not affect axon length (supplementary Fig. 1). 
Hence lentiviral delivery of ALS mutant SOD1 in embryonic rat motor neurons caused impairment 
of axonal transport of mitochondria similar to that reported in embryonic SOD1 G93A transgenic 
mouse motor neurons and transfected cortical neurons (9). Taken together these data also indicate 
that for the purpose of studying the effect of ALS mutant SOD1 on axonal transport of 
mitochondria, the method of delivery of SOD1, transfection or lentiviral transduction, and the 
neuronal cell type, cortical or motor neurons, are interchangeable.  
 
ALS mutant SOD1 does not affect cytosolic Ca
2+ 
levels 
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We reported previously that expression of the ALS type-8 (ALS8)-associated vesicle-associated 
membrane protein-associated protein B (VAPB) mutant VAPBP56S in rat cortical neurons impairs 
anterograde transport of mitochondria similar to ALS mutant SOD1 (29). Mechanistically, 
overexpression of VAPBP56S increased cytosolic Ca2+ levels ([Ca2+]c), which caused a reduction 
in the amounts of tubulin but not kinesin-1 that were associated with Miro1 and as a consequence 
transport was arrested (29, 30).  
To investigate whether elevated [Ca2+]c also played a role in ALS mutant SOD1-induced defective 
axonal transport of mitochondria, we examined resting [Ca2+]c in cortical neurons expressing 
EGFP, EGFP-SOD1 WT or G93A by Fura2 ratio imaging. To identify viable neurons we induced 
a transient Ca2+ influx by depolarization with 50 mM KCl; only viable neurons were included in 
the analyses of resting [Ca2+]c. There was no difference in resting [Ca
2+]c in EGFP, EGFP-SOD1 
WT and EGFP-SOD1 G93A-expressing neurons, suggesting that the axonal transport defect in 
ALS mutant SOD1 expressing neurons is not driven by changes in [Ca2+]c (Fig. 2; supplementary 
Fig. 2).  
 
ALS mutant SOD1 reduces Miro1 levels in a Parkin-dependent fashion 
It is well established that ALS mutant SOD1 accumulates in mitochondria and causes 
mitochondrial damage (7), and mitochondrial dysfunction has been linked to Miro1 degradation 
and impairment of axonal transport of mitochondria (23). Furthermore, Miro1 levels have been 
shown to be decreased in the spinal cord of transgenic mice expressing ALS mutant SOD1 G93A 
(31). To investigate if reduced levels of Miro1 may be at the basis of the axonal transport defect 
in SOD1-related ALS we first explored if expression of ALS mutant SOD1 could affect Miro1 
levels in HEK293 cells and primary cortical neuron cultures.  
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We co-transfected HEK293 cells with myc-tagged Miro1 (Myc-Miro1) and EGFP-SOD1 WT, 
A4V, G93A, G37R or G85R and quantified Myc-Miro1 levels on immunoblots. Compared to 
SOD1 WT all four ALS-associated SOD1 mutants caused a decrease in Myc-Miro1 levels of 
approximately 20% (Fig. 3A). We next determined if ALS mutant SOD1 affected the amount of 
endogenous Miro1 in rat cortical neurons transduced with EGFP-SOD1 WT or G93A. In these 
samples, endogenous Miro1 was readily detected on immunoblots as a doublet with a molecular 
weight of approximately 80 kDa as described before (32). Compared to SOD1 WT, ALS mutant 
SOD1 G93A significantly reduced the level of endogenous Miro1 in cortical neurons indicating 
that the ALS mutant SOD1-associated impairment of mitochondrial axonal transport may be due 
to reduced Miro1 levels (Fig. 3B). 
To further investigate the involvement of the PINK1/Parkin pathway in ALS mutant SOD1-
induced reductions in Miro1 levels we took advantage of HeLa cells that lack endogenous Parkin 
(33, 34). We co-transfected HeLa cells with EGFP-SOD1 WT or ALS mutant SOD1 G93A and 
myc-Miro1 and determined Miro1 levels. ALS mutant SOD1 G93A did not affect Miro1 levels in 
native HeLa cells lacking Parkin (Fig. 3C). To confirm that this lack of effect of SOD1 G93A was 
indeed due to Parkin deficiency we restored Parkin expression by co-transfection of YFP-Parkin. 
It has been shown previously that expression of YFP-Parkin in HeLa cells restores the 
PINK1/Parkin pathway (35). In presence of YFP-Parkin ALS mutant SOD1 G93A caused a 
marked decrease in Miro1 compared to SOD1 WT (Fig. 3C). 
Together these data indicate that ALS mutant SOD1 induces PINK1/Parkin-dependent degradation 
of Miro1. 
 
Expression of Miro1 rescues the effects of ALS mutant SOD1 on mitochondrial motility  
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To further investigate the role of Miro1 in the axonal transport defects observed in ALS mutant 
SOD1-expressing neurons we enquired if expressing wild type Miro1 or a Ca2+ insensitive mutant 
of Miro1 in which the EF hands were disrupted (Miro1E208K/E328K) could rescue the effect of ALS 
mutant SOD1 on mitochondrial transport. Expression of either wild type Miro1 or Miro1E208K/E328K 
should rescue the effect of ALS mutant SOD1 on mitochondrial transport if the defect was caused 
by reduced levels of Miro1, but only Miro1E208K/E328K should rescue if the defect was Ca2+ 
dependent. Indeed, we have previously shown that in agreement with a Ca2+ dependent 
mechanism, expression Miro1E208K/E328K but not wild type Miro1 rescued defective mitochondrial 
axonal transport in VAPBP56S-expressing cortical neurons (29). 
We co-expressed Miro1 or Miro1E208K/E328K with EGFP SOD1 WT or G93A in rat primary cortical 
neurons and quantified transport of mitochondria. In SOD1 WT-expressing neurons 
Miro1E208K/E328K but not Miro1 lowered the number of retrograde mitochondria (Fig. 4A, b). As a 
result, mitochondrial transport was skewed toward net anterograde transport in SOD1 WT + 
Miro1E208K/E328K expressing neurons (Fig. 4A, c). In these neurons, the number of anterograde 
mitochondria was slightly elevated but not to a significant extent. These data are consistent with 
the previously proposed model in which binding of Ca2+ to the EF hands of Miro1 enables 
retrograde transport by inactivation of kinesin-1-mediated anterograde transport (24, 25). 
Compared to SOD1 WT, transfection of SOD1 G93A alone again reduced anterograde transport 
of mitochondria and consequently shifted the balance of transport toward net retrograde transport 
(Fig. 4A, b and c). Both wild type Miro1 and Miro1E208K/E328K fully rescued anterograde axonal 
transport (Fig. 4A, b) and restored the balance of transport in SOD1 G93A-expressing neurons 
(Fig. 4A, c).  
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The rescue by wild type Miro1 was further confirmed in motor neurons by quantification of axonal 
transport of mitochondria in rat motor neurons co-transduced with wild type Miro1 and EGFP-
SOD1 WT or G93A (Fig. 4B). Expression of SOD1 G93A in absence of wild type Miro1 reduced 
anterograde axonal transport of mitochondria compared to SOD1 WT and, as was the case in 
cortical neurons, co-expression of wild type Miro1 fully rescued the effect of SOD1 G93A on 
mitochondrial transport (Fig. 4B, b and c). Together these data confirm that ALS mutant SOD1 
does not act via Ca2+ but by reducing Miro1 levels to affect anterograde transport of mitochondria. 
 
Knockdown of PINK1 rescues the effects of ALS mutant SOD1 on mitochondrial motility  
The above data strongly suggested that ALS mutant SOD1 impairs axonal transport of 
mitochondria by triggering PINK1/Parkin-dependent degradation of Miro1. To further verify this 
mechanism, we disrupted the PINK1/Parkin pathway by ablation of PINK1 expression using 
miRNA in cortical and motor neurons expressing EGFP-SOD1 WT or G93A and analysed axonal 
transport of mitochondria. As control, we used a non-targeting control miRNA. The efficiency of 
the PINK1 miRNA-mediated knockdown was verified by qRT-PCR; on average 70% knockdown 
was achieved (supplementary Fig. 3). 
In non-targeting control miRNA + SOD1 WT expressing cortical and motor neurons 
approximately half of mitochondria were motile and these were near equally divided into 
anterograde and retrograde mitochondria (Fig. 5A and B, a and b). Control miRNA + SOD1 G93A-
expressing cortical and motor neurons exhibited impaired anterograde transport of mitochondria 
(Fig. 5A and B, a and b) and this caused a shift toward net retrograde transport (Fig. 5A and B, c). 
Thus, control miRNA did not affect transport per se and did not alter SOD1 G93A-associated 
reductions in anterograde transport (compare with Fig. 1). In contrast, whereas PINK1 miRNA did 
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not affect axonal transport of mitochondria in SOD1 WT-expressing cortical or motor neurons, it 
fully restored anterograde transport in SOD1 G93A-expressing neurons to control levels (Fig. 5A 
and B, b) and rebalanced transport (Fig. 5A and B, c). Thus, in agreement with a PINK1/Parkin-
dependent reduction in Miro1 levels as the underlying cause of the ALS mutant SOD1-associated 
defect in mitochondrial trafficking, miRNA-mediated knockdown of PINK1 rescued 
mitochondrial axonal transport in SOD1 G93A-expressing cortical and motor neurons. 
 
Discussion 
Defective axonal transport of mitochondria and other cargoes is one of the earliest 
neuropathological features observed in models of ALS which has led to the suggestion that it may 
play a causative role in disease (5). Mutations in essential axonal transport components such as 
cytoplasmic dynein, kinesin-1 and tubulin that have been shown to cause ALS and other motor 
neuron disorders, have reinforced this idea. We and others have shown that axonal transport of 
mitochondria is impaired in in vitro and in vivo models of mutant SOD1-related ALS but the 
underlying causes of defective transport remained unclear (9Ð12, 36, 37). 
Here we show that impaired axonal transport of mitochondria in mutant SOD1-expressing neurons 
correlates with reduced levels of Miro1 (Fig. 3). Degradation of Miro1 has been shown to be an 
early event in PINK1/Parkin-dependent mitophagy. In mitophagy, mitochondrial damage causes 
stabilisation of PINK1 on the outer mitochondrial membrane where PINK1 phosphorylates 
ubiquitin which in turn drives recruitment of Parkin, itself a PINK1 substrate, to the mitochondria 
(38). PINK1 also phosphorylates Miro1 which targets Miro1 for degradation in a Parkin-dependent 
manner (23). As a consequence, molecular motors are prevented from attaching to mitochondria 
and damaged mitochondria are immobilised. Consistent with PINK1-dependent reduction of 
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Miro1 levels perturbing transport of mitochondria, expression of Miro1 and ablation of PINK1 
rescued axonal transport in ALS mutant SOD1-expressing cortical and motor neurons (Fig. 4 and 
5). Furthermore, Miro1 degradation assays directly confirmed the Parkin dependent degradation 
of Miro1 (Fig. 3). It is well-established that ALS mutant SOD1 accumulates in mitochondria where 
it interacts with voltage-dependent anion channel 1 (VDAC1) and Bcl-2, and causes mitochondrial 
dysfunction (39Ð45). Thus, our data suggest that mutant SOD1-induced mitochondrial damage 
activates the PINK1/Parkin pathway and as a result halts mitochondrial transport. In line with such 
a model it has been shown that Miro1-expression is decreased in the spinal cord of SOD1 G93A 
transgenic mice (31). 
We previously reported that mutant VAPBP56S deregulates Ca2+ homeostasis leading to increased 
[Ca2+]c that impairs mitochondrial transport by binding to the EF hand motifs of Miro1 (29). In 
vitro data on [Ca2+]c in ALS mutant SOD1 expressing neurons is conflicting. SH-SY5Y cells stably 
expressing SOD1 G93A have been shown to have in increased [Ca2+]c. In contrast, both unchanged 
(46, 47) and increased [Ca2+]c (48) has been found in SOD1 G93A transgenic motor neuron 
cultures. In fact, a meta-analysis of 26 [Ca2+]c values from 9 studies, found that half of the data 
points show elevated [Ca2+]c and half show lower [Ca
2+]c in SOD1 G93A expressing neurons 
compared to SOD1 WT (49). We did not find any change in basal [Ca2+]c upon ALS mutant SOD1 
expression (Fig. 2 and supplementary Fig. 2) and consistent with a Ca2+-independent mechanism 
both wild type and mutant Miro1 were able to restore axonal transport of mitochondria in ALS 
mutant SOD1 expressing neurons (Fig. 4). Thus, two distinct genetic causes of ALS, mutant VAPB 
and mutant SOD1, that impair axonal transport of mitochondria converge on Miro1 to halt 
transport, albeit by different mechanisms.  
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Impaired axonal transport of mitochondria has also been observed in models of TDP-43, FUS, 
SIGMAR1 and C9orf72-related ALS (29, 36, 50Ð53). Furthermore, neuropathological studies of 
post-mortem ALS cases have revealed accumulations of mitochondria in the proximal segment of 
motor neurons and in axonal spheroids which are indicative of damaged axonal transport (54Ð56). 
It is not yet clear what the underlying causes of impaired axonal transport of mitochondria are in 
these cases, but mitochondrial damage and calcium mishandling are well-documented in all of 
ALS (7, 57). Both ALS mutant TDP-43 and FUS have been shown to accumulate in mitochondria 
and disrupt mitochondrial function (58, 59). C9orf72 GGGGCC repeat expansion-associated 
glycine/arginine (GR) dipeptide repeat protein (DPR) has been shown to bind to mitochondrial 
ribosomes and compromise mitochondrial function (60). Mitochondria appear swollen and 
vacuolated in motor neurons of ALS patients (54). TDP-43, FUS, and SIGMAR1 have all been 
linked to Ca2+ mishandling, probably due to disruption of ER-mitochondria contact sites (53, 61Ð
65), and evidence suggests altered Ca2+ in the motor terminals of ALS patients (66). In agreement 
with mitochondrial damage-associated reductions in Miro1 causing axonal transport defects in 
non-SOD1 ALS, decreased levels of Miro1 have been reported in TDP-43 M337V transgenic mice 
and ALS patients (31), and, in case of FUS, a genetic interaction with PINK1/Parkin has been 
described in Drosophila (52). Thus, several ALS-associated insults may converge on axonal 
transport via Miro1 and trigger motor neuron demise. 
Defective axonal transport of mitochondria leading to depletion of mitochondria from axons is one 
of the earliest phenomena observed in ALS models and have been proposed to play an important 
causal role in disease (5). However, increasing the motility of mitochondria in SOD1 G93A 
transgenic mice did not slow disease in these animals (67). Our data now suggest that 
mitochondrial damage is the upstream cause of defective axonal transport of mitochondria in 
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mutant SOD1-associated ALS. Hence it may not be surprising that stimulating anterograde 
transport of damaged mitochondria did not alter the course of disease in SOD1 G93A transgenic 
mice. Indeed, our findings indicate that, at least in the case of ALS mutant SOD1, the relative 
increase in retrograde transport of mitochondria at the cost of anterograde transport represents 
increased clearance for damaged mitochondria via mitophagy. If this is also the case in non-SOD1 
ALS is not yet clear but these results suggest that successful therapeutic strategies will probably 
need to target both mitochondrial dysfunction and transport simultaneously.  
 
Materials and Methods 
Plasmids 
pDsRed2-Mito and pEGFPc2 were purchased from Clontech. pEGFPc2-SOD1 and pRK5-myc-
Miro1E208K/E328K expression constructs have been described before (9, 29). pRK5-myc-Miro1 was 
a gift from P. Aspenstrm (Karolinska Institutet, Stockholm, Sweden (17). pCMV-dR8.92 was a 
gift from Bob Weinberg via Addgene (plasmid #8455) (68). pMD2.G and pRSV-Rev were both 
gifts from Didier Trono via Addgene (plasmid #12253 and #12259) (69). YFP-Parkin was a gift 
from Alexander Whitworth (MRC Mitochondrial Biology Unit, Cambridge, UK). 
A rat PINK1-targeting miRNA expression construct was designed using InvitrogenÕs RNAi 
Designer (www.invitrogen.com/rnai) and cloned into the pcDNA6.2TM-GW/EmGFP-miR 
expression vector according to the manufacturerÕs instructions (BLOCK-iTTM Pol II miR RNAi 
expression vector kit, Invitrogen). Sequences for the top strands were 5Õ-TGC TGT GTC CTA 
TCA GAT AAT CCT CCG TTT TGG CCA CTG ACT GAC GGA GGA TTC TGA TAG GAC 
A (PINK1) and 5Õ-TGC TGA AAT GTA CTG CGC GTG GAG ACG TTT TGG CCA CTG ACT 
GAC GTC TCC ACG CAG TAC ATT T (negative control; provided with the kit). In order to 
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exchange the EmGFP tag for a ECFP tag, ECFP was amplified using primers 5Õ-TTT AAA ACC 
ATG GTG AGC AAG GGC GAG GAG (fw) and 5Õ-TTT AAA CGA TCT TAC TTG TAC AGC 
TCG TCC ATG CC (rev) from pECFP (Clontech). After sub-cloning into pCR¨-Blunt II-TOPO 
(Life Technologies), ECFP was cloned into pcDNA6.2TM-GW/EmGFP using DraI sites (Thermo 
Scientific).  
For lentiviral transduction EmGFP or ECFP-miR-PINK1 and EGFP-SOD1 expression constructs, 
were subcloned in pLvos (70) using NheI and NotI sites yielding pLvos-EmGFP or ECFP-miR-
PINK1, pLvos-EGFP-SOD1 WT, A4V, G37R and G93A. Virus production was as described 
before (70). 
 
Cell culture, plasmid transfection, lentiviral transduction 
Cortical neurons from E18 rat embryos were isolated and cultured as described before (9, 28, 70). 
375,000 cells were seeded onto 18 mm cover slips coated with poly-L-lysine. Cells were cultured 
for 5-7 d and then transfected with Lipofectamine LTX (Life Technologies; 0.5 µl/µg of DNA). 
Transduction with lentiviruses was performed on DIV5 using an MOI of 5.  
Motor neurons from E15 rat embryos were isolated as described before (71) and cultured in 
Neurobasal¨ Medium (Life Technologies) supplemented with 2% (v/v) B-27¨ supplement (Life 
Technologies), 2% (v/v) heat-inactivated horse serum (Sigma), 2 mM GlutaMAXTM-I (Life 
Technologies), 25 µM L-glutamic acid (Sigma), 5 ng/ml brain-derived neurotrophic factor 
(BDNF), 10 ng/ml glial cell-derived neurotrophic factor (GDNF) and 10 ng/ml ciliary neurotrophic 
factor (CNTF; all neurotrophic factors were purchased from R&D Systems). 40,000 motor neurons 
were seeded onto 18 mm cover slips coated with poly-DL-ornithine (Sigma) and Laminin (Life 
Technologies). Transduction with lentiviruses was performed on DIV 0 using an MOI of 5.  
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HEK293 and Hela cells were cultured in high glucose DulbeccoÕs Modified EagleÕs Medium 
(DMEM, Sigma) supplemented with 10% foetal calf serum (Sigma). HEK293 cells were 
transfected using Lipofectamine 2000 according to the manufacturerÕs protocol (Life 
Technologies); Hela cells were transfected using polyethyleneimine (PEI, 1 mg/ml; 3:2 PEI:DNA). 
 
Antibodies 
Mouse monoclonal anti-myc-tag antibody (9B11; 1:2000) was from Cell Signaling Technology, 
mouse monoclonal anti-GFP antibody (JL8; 1:5000) was from Clontech, rabbit polyclonal anti-
RHOT1 antibody (1:1000), mouse monoclonal anti-RHOT1 (4H4; 1:1000), mouse monoclonal 
anti-actin (4C2; 1:5000) and mouse monoclonal anti-α-tubulin antibody (DM1A; 1:10,000) were 
from Sigma. Secondary antibodies used for immunoblotting were horseradish peroxidase-coupled 
goat anti-rabbit and rabbit anti-mouse IgG from Dako (1:5000), and alkaline phosphatase-coupled 
goat anti-mouse and goat anti-rabbit IgG antibodies from Sigma (1:10,000). 
 
Miro1 assays 
For Myc-Miro1 assays in HEK293 cells, cells were transfected with equal amounts of Myc-Miro1 
and either EGFP-SOD1 WT, A4V, G37R, or G93A. Cells were processed for immunoblot 24 h 
after transfection. In case of cortical neurons, the neurons were transduced at 5DIV and 
endogenous Miro1 levels were determined on immunoblot 10 days after lentiviral transduction. 
HeLa cells were transfected with Myc-Miro1, EGFP-SOD1 WT or G93A, and YPP-Parkin or 
pciNeo empty vector (ratio: 1:2:1). Myc Miro1 levels were determined 48-72h after transfection. 
 
SDS-PAGE and immunoblot 
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Samples were separated on poly-acrylamide gels and transferred to Protran nitrocellulose 
membranes (0.45 µm, GE Healthcare) using a Pierce G2 Fast Blotter (Thermo Scientific) or Bio-
Rad TransBlot cell. Membranes were blocked for 1 h at room temperature in TBS containing 5% 
milk powder/0.1% Tween-20 (TBST-M) and probed with primary antibodies in TBST-M for either 
1 h at room temperature or 16 h at 4oC. After washing with TBS/0.1% Tween-20 (TBST), 
membranes were incubated with horseradish peroxidase (HRP)-conjugated or alkaline 
phosphatase (AP)-coupled, species-specific secondary antibodies. Following incubation with 
SuperSignal West Pico Chemiluminescence Substrate (Thermo Scientific) or AttoPhos¨ AP 
Fluorescent Substrate (Promega) signals were detected on Hyperfilm ECL (GE Healthcare) or 
using a G:Box imager (Syngene). Films were scanned on a CanoScan LiDE 60 photo scanner and 
signals were quantified using the Fiji distribution (http://fiji.sc/) (72) of the ImageJ image 
processing software (National Institutes of Health (NIH), http://rsb.info.nih.gov/ij/) (73). 
 
Mitochondrial transport assays  
For axonal transport assays in cortical neurons, 0.7 µg of pEGFPc2, or pEGFPc2-SOD1 were 
transfected together with 0.3 µg of pDsRed2-Mito or 0.2 µg of pDsRed2-Mito + 0.1 µg of either 
pRK5-myc-Miro1, Miro1E208K/E328K or pcDNA6.2TM-GW/EmGFP-miR-PINK1. Motor neurons 
were transduced with lentiviruses on DIV0 using an MOI of 5. 
Live microscopy of mitochondrial axonal transport was performed using an Axiovert200 
microscope (Carl Zeiss) equipped with a Polychrome IV monochromator (Till Photonics), an 
EGFP/DsRed filter set (Chroma Technology Corp.), a 40X EC Plan-Neofluar 1.3 N.A. objective 
(Zeiss), a high speed HF110A emission filter wheel controlled by a ProScan III Controller (Prior 
Scientific) and a Hamamatsu C9100-12 EMCCD camera (Hamamatsu Photonics). The microscope 
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setup was controlled using MicroManager 1.4.21 (74). 48 h post-transfection or 72 h post-
transduction, coverslips were transferred to a heated observation chamber (SA-20LZ, Warner 
Instruments) mounted on the stage of the microscope. In order to visualise mitochondria, motor 
neurons were stained with MitoTracker¨ Red CMXRos (66 nM, Life Technologies) beforehand. 
In addition to the heated chamber, an objective heater (IntraCell) was used to maintain the cells at 
37oC. Mitochondrial movements were recorded for 5 min with 3 s time-lapse interval in 
Neurobasal medium (Life Technologies) supplemented with 5 mM HEPES pH 7.0 and 2 mM 
GlutaMAXª-I. Axonal transport was analysed using ImageJ as described previously (9, 28, 29). 
Briefly, the overall transport of mitochondria was quantified from kymographs by calculating the 
distance between the position of individual mitochondria at the start and end of time-lapse 
recordings and dividing by the time elapsed. This yielded an average transport velocity for each 
mitochondrion that includes anterograde and retrograde movements and stationary periods. 
Mitochondria were classified as motile when their velocity exceeded 0.1 µm/s or as stationary 
when their velocity was ≤0.1 µm/s. Mitochondria were classified as anterograde or retrograde 
according to their predominant direction of travel.  
 
Ca
2+
 imaging 
Resting [Ca2+]c levels in transfected cortical neurons were determined by Fura2 ratio imaging as 
described previously (29). First, cells were stained for 20 min at 37oC with 5 µM Fura2/AM (Life 
Technologies) in external solution (ES; 145 mM NaCl, 2 mM KCl, 5 mM NaHCO3, 1 mM MgCl2, 
2.5 mM CaCl2, 10 mM glucose, 10 mM HEPES pH 7.0). After destaining by incubation for another 
20 min in ES only, Fura2 340 nm / Fura2 380 nm image pairs were recorded for 400 s with 1 s 
time-lapse interval using the same microscopy setup as described above, but using WinFluor 
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V3.7.4 software (written by John Dempster, University of Strathclyde; 
http://spider.science.strath.ac.uk/sipbs/software_imaging.htm). Neurons were perfused 
continuously with ES (2 ml/min; Gilson Minipuls Evolution). To ensure that only viable neurons 
were taken into account, a transient Ca2+ influx was invoked by depolarisation with 50 mM KCl 
for 1 min. Signals were recorded and analysed using the WinFluor software. 
 
Quantitative real time PCR 
RNA from cultured cells was isolated according to the manufacturerÕs instructions using TRIzol¨ 
Reagent (Life Technologies). After resuspension in nuclease-free water, 0.5-2 µg RNA were 
treated with DNase I (NEB; DNase I was inactivated by addition of 2.5 mM EDTA (final 
concentration) and incubation for 10 min at 75oC) and reverse transcribed using SuperScript¨ III 
Reverse Transcriptase and Oligo(dT) primers (Thermo Scientific). 100 ng of template was 
subjected to a quantitative real time PCR utilising Brilliant III Ultra-Fast 2x SYBR¨ Green QPCR 
master mix (Agilent Technologies) or HOT Firepol EvaGreen PCR Mix Plus (Solis Biodyne) using 
an Mx3000p qPCR System (Agilent Technologies) or a BioRad CFX96 Real-Time System (C1000 
Touch Thermal Cycler; BioRad). PINK1 primers were as follows: rnPINK1 fw: 5Õ-TGT CAG 
GAG ATC CAG GCA ATT, rnPINK1 rev: 5Õ-CTT CAT ACA CAG CGG CAT TGCA, GAPDH 
or RPL19 was used as endogenous control: rnGAPDH fw: 5Õ-TGA AGG GTG GGG CCA AAGG, 
rnGAPDH rev: 5Õ-GGT CAT GAG CCC TTC CAT GA, rnRPL19 fw: 5'- CTC GAT GCC GGA 
AGA ACA CC -3', rnRPL19 rev: 5'- GAG CGT TGG CAG TAC CCT T -3' 
 
Statistical analysis 
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Calculations and statistical analysis were performed using Excel (Microsoft Corporation) and 
GraphPad Prism software (GraphPad Software).  
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Legends to Figures 
Figure 1. ALS mutant SOD1 impairs axonal transport of mitochondria. Axonal transport of 
mitochondria was analysed in motor neurons (A) and cortical neurons (B). (Aa, Ba) Kymographs 
show transport of mitochondria in rat motor neurons and cortical neurons expressing EGFP (Ctrl), 
EGFP-SOD1 WT, A4V, G37R or G93A. (Ab, c; Bb, c) Quantitative analysis of mitochondrial 
transport shows that expression of ALS mutant SOD1 significantly impairs overall motility of 
mitochondria (Ab, Bb Ð Motile) because of a selective block of anterograde (Ab, Bb Ð 
Anterograde), but not retrograde (Ab, Bb Ð Retrograde) transport. As a consequence, SOD1 G93A 
disturbed the balance of transport to promote net retrograde movement (Ac, Bc). Results are shown 
as mean ± SEM, statistical significance was determined by one-way ANOVA followed by FisherÕs 
LSD test, ns, not significant, * P< 0.05, **** P<0.0001, N (cortical neurons): Ctrl: 24, WT: 21, 
G93A: 24 from 5 experiments; N (motor neurons) = Ctrl: 16, WT: 20, A4V: 20, G37R: 21, G93A: 
21 from 3 experiments. 
 
Figure 2. ALS mutant SOD1 G93A does not affect resting [Ca
2+
]c.  
Cortical neurons were transduced with EGFP, EGFP-SOD1 WT or G93A lentivirus and [Ca2+]c 
determined by of Fura2 ratio imaging. To ensure that only viable neurons were taken into account, 
a transient Ca2+ influx was invoked by depolarisation with 50 mM KCl. Average Ca2+ traces are 
shown in (a). Resting [Ca2+]c was calculated as the average [Ca
2+]c between 50 and 150 s of 
recording and values for individual cells averaged to generate the bar graphs in (b). SOD1 G93A 
did not change resting [Ca2+]c in comparison to EGFP control or SOD1 WT-expressing neurons. 
Results are shown as mean ± SEM, statistical significance was determined by one-way ANOVA, 
N (cells) = EGFP: 32, WT: 36, G93A: 37 from 3 experiments. 
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Figure 3. ALS mutant SOD1 reduces Miro1 expression levels via Parkin.  
(A, B) Western blot analysis of myc-Miro1 levels in HEK293 cells expressing EGFP-SOD1 WT, 
A4V, G93A, or G37R (A) or of endogenous Miro1 in cortical neurons expressing EGFP-SOD1 
WT or G93A (B). ALS mutant SOD1 caused a decrease in Miro1 levels. Miro1 levels were 
corrected for loading using the α-tubulin or actin loading control and are shown relative to SOD1 
WT. Expression of EGFP-SOD1 was verified on separate blots. (C) Western blot analysis of myc-
Miro1 levels in HeLa cells expressing EGFP-SOD1 WT or G93A with or without co-expression 
of YFP-Parkin. ALS mutant SOD1 G93A-induced degradation of Miro1 was Parkin dependent. 
Results are shown as mean ± SEM, statistical significance was determined by (A) one-way 
ANOVA followed by FisherÕs LSD test, N= WT:8, A4V:7, G37R: 6, G85R: 8, G93A: 8, (B) 
unpaired t-test, N = 4, or (C) one-way ANOVA followed by FisherÕs LSD test, N=6, ns not 
significant, * P< 0.05, ** P<0.01, *** P<0.001. 
 
Figure 4. Expression of Miro1 rescues axonal transport of mitochondria in ALS mutant SOD1 
expressing neurons. 
(Aa, Ba) Kymographs show transport of mitochondria in rat cortical neurons and motor neurons 
co-expressing EGFP-SOD1 WT or G93A with empty vector (Ctrl), myc-Miro1 (WT), or Myc-
Miro1E208K/E328K (KK). (Ab, c; Bb, c) Quantitative analysis of mitochondrial transport shows that 
expression of ALS mutant SOD1 significantly impairs overall motility of mitochondria (Ab, Bb Ð 
Motile) because of a selective block of anterograde (Ab, Bb Ð Anterograde), but not retrograde 
transport (Ab, Bb Ð Retrograde). As a consequence, SOD1 G93A disturbed the balance of transport 
to inhibit anterograde and promote retrograde movement (Ac, Bc). Co-expression of myc-Miro1 
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WT or KK, fully rescued impaired transport of mitochondria (Ab, Bb) and rebalanced anterograde 
and retrograde transport (Ac, Bc). Results are shown as mean ± SEM, statistical significance was 
determined by one-way ANOVA followed by FisherÕs LSD test, ns, not significant, * P< 0.05, 
*** P<0.001, **** P<0.0001, N (cortical neurons): SOD1 WT+Ctrl: 18, SOD1 WT+WT: 24, 
SOD1 WT+KK: 23, SOD1 G93A+Ctrl: 20, SOD1 G93A+WT: 24, SOD1 G93A+KK: 22 from 4 
experiments; N (motor neurons) = WT+Ctrl: 15, SOD1 WT+WT: 16, SOD1 G93A+Ctrl: 19, 
SOD1 G93A+WT: 29 from 5 experiments. 
 
Figure 5. Knockdown of PINK1 rescues axonal transport of mitochondria in ALS mutant SOD1 
expressing neurons. 
(Aa, Ba) Kymographs show transport of mitochondria in rat cortical neurons and motor neurons 
co-expressing EGFP-SOD1 WT or G93A with non-targeting control miRNA (Ctrl) or PINK1-
targeting (PINK1) miRNA. (Ab, c; Bb, c) Quantitative analysis of mitochondrial transport shows 
that expression of ALS mutant SOD1 significantly impairs overall motility of mitochondria (Ab, 
Bb Ð Motile) because of a selective block of anterograde (Ab, Bb Ð Anterograde), but not 
retrograde transport (Ab, Bb Ð Retrograde). As a consequence, SOD1 G93A disturbed the balance 
of transport to inhibit anterograde and promote retrograde movement (Ac, Bc). Ablation of PINK1 
expression fully rescued impaired transport of mitochondria (Ab, Bb) and rebalanced anterograde 
and retrograde transport (Ac, Bc). Results are shown as mean ± SEM, statistical significance was 
determined by one-way ANOVA followed by FisherÕs LSD test, ns, not significant, * P< 0.05, 
*** P<0.001, **** P<0.0001, N (cortical neurons): SOD1 WT+Ctrl: 25, SOD1 WT+PINK1: 32, 
SOD1 G93A+Ctrl: 39, SOD1 G93A+PINK1: 35 from 4 experiments; N (motor neurons) = SOD1 
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WT+Ctrl: 13, SOD1 WT+PINK1: 19, SOD1 G93A+Ctrl: 16, SOD1 G93A+PINK1: 27 from 4 
experiments. 
 
 
Supplementary Figure 1: Expression of ALS mutant SOD1 does not affect axon length. Axon 
length was determined in rat cortical neurons transfected with EGFP, EGFP-SOD1 WT, A4V, 
G37R or G93A. Results are shown as mean ± SEM, statistical significance was determined by 
one-way ANOVA followed by FisherÕs LSD test, N = 10 neurons. 
 
Supplementary Figure 2: ALS mutant SOD1 G93A does not affect resting [Ca
2+
]c.  
Cortical neurons were transfected with EGFP, EGFP-SOD1 WT or G93A and [Ca2+]c determined 
by of Fura2 ratio imaging. To ensure that only viable neurons were taken into account, a transient 
Ca2+ influx was invoked by depolarisation with 50 mM KCl. Average Ca2+ traces are shown in (a). 
Resting [Ca2+]c was calculated as the average [Ca
2+]c between 50 and 150 s of recording and values 
for individual cells averaged to generate the bar graphs in (b). SOD1 G93A did not change resting 
[Ca2+]c in comparison to EGFP control or SOD1 WT-expressing neurons. Results are shown as 
mean ± SEM, statistical significance was determined by one-way ANOVA, N (cells) = EGFP: 17, 
WT: 24, G93A: 26 from 3 experiments. 
 
Supplementary Figure 3: miRNA-mediated knockdown of PINK1 in cortical neurons. Non-
targeting control miRNA (Ctrl) or PINK1 miRNA were delivered in cortical neurons using 
lentivirus. Relative PINK1 mRNA levels were determined by qRT-PCR. 
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Abbreviations 
Amyotrophic lateral sclerosis, ALS; Cu/Zn superoxide dismutase 1, SOD1; calcium, Ca2+; 
cytosolic calcium levels, [Ca2+]c; mitochondrial Rho GTPase 1, Miro1; Phosphatase and Tensin 
homolog, PTEN; PTEN-induced putative kinase 1, PINK1; TAR DNA binding protein, TARDBP, 
TDP-43; Fused in sarcoma, FUS; Trafficking Kinesin protein, TRAK; Enhanced green fluorescent 
protein, EGFP; millimolar, mM; millilitre, ml; min, minute; hour, h; second, s. 








